| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Outsourcing > Electronic Medical Billing Software and Service Compliance in Chiropractic Office |
|
Subjects - Electronic Medical Billing Software and Service Compliance in Chiropractic Office
Over the course of the past two decades, federal and state enforcement agencies have investigated medical billing incidents and brought multiple enforcement actions against healthcare practices. The list of agenci According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product es tasked with billing compliance enforcement includes federal Department of Justice, the Office of Inspector General (OIG) at the Department of Health and Human Service, state Medicaid fraud control units, and ot ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ers. The number of medical billing fraud investigations and enforcement actions has been steadily growing. For instance, according to BillingWiki, thirteen articles and news items were published on the topic of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. edical billing fraud during May of 2006. In addition to growing frequency of incidents, the severity of penalties has also escalated from relatively non-adversarial audits and occasional return of payments to fin here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s, suspension or loss of license, and imprisonment. Six out of thirteen news items and articles about medical billing fraud published in May 2006 involve chiropractors (BillingWiki/Compliance). The remaining ite d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s are distributed more or less evenly across such specialties as psychiatry, gynecology, neurology, orthopedics, and aged care. The growing frequency of audits and increasing severity of penalties are symptomatic ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc of inadequate attention to billing compliance at the chiropractic office. An insurance company typically performs post-payment audit by soliciting medical notes for a random sample of paid claims during the previ easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ous year. Next, the proportion of inadequate medical notes defines the overpayment percentage. The total amount of overpayment is then calculated by applying the overpayment percentage to all payments over the p nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically st six years. Billing compliance is doctor's responsibility and ignoring it often results in practice ruin. To avoid billing audit risks, some doctors have elected to work on cash-only basis, collecting cash pay and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ents directly from the patients instead of submitting medical claims to insurance agencies. However, such tactics does not help avoid the potential audit because patients submit requests to pay the claim to the h ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi althcare insurance company on their own. Since the top two reasons for post-payment audits are over utilization of certain CPT codes and hot line calls by patients and staff, the best strategy to manage post-paym ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nt audit risk has three prongs: 1. Formal compliance program, 2. Competent management of medical notes, and 3. Continuous monitoring of potential audit triggers. First, the existence of a compliance dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rogram may determine whether the payer can routinely handle the matter as an innocent overpayment mistake or it must be investigated by the OIG as a potentially fraudulent act. Next, careful management of medical cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin notes is a basis for a successful audit defense, which often reduces the damages significantly and helps avoiding a repeat audit a few years later. Finally, audit trigger monitoring ensures compliance of both cum tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ulative service patterns across multiple patients and individual treatments. Real-time juxtaposition of histograms of CPT code frequencies between practice and national averages compares service patterns and aler t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s of potential compliance infringements. Individual treatment compliance is ensured when no specific CPT code exceeds its monthly limits, such as billing a 9894X on each visit, or billing a 97140 manual therapy i ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust place of a manipulation code because it pays more, or charging for 97149 together with 9894X, while both procedures linked to the same diagnosis. In the latter example, performing both an adjustment and a soft t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ssue manipulation in the same part of the body for the same complaint is illegal and a repeat submission of such a claim may trigger an audit. An environment of high volume of patient encounters creates thousands . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de of possibilities to deviate from normal distribution of services and trigger an audit. Therefore, real time analysis requires powerful technology infrastructure and competent legal coverage. Such infrastructure elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ust handle all compliance aspects together, which necessitates modern Vericle-type integrative approach, combining billing, monitoring, and medical record management components in a single and comprehensive system tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Making Time For Both Your Home Business and Your Family When Networking Stop Selling to Salesmen
|